Immune Checkpoint Inhibitors and Mesenchymal Stem/Stromal Cells Combination Therapy Might Offer a Promising Treatment Option for Cancer

Journal article

Peer reviewed

Ahmed Lotfy and Hongjun Wang

Stem cell reviews and reports, Vol.19(3), pp.823-824

04/2023

PMID: 36454388

Web of Science ID: WOS:000912614100001

Metrics

1 Record Views

Combined Modality Therapy

Immune Checkpoint Inhibitors - pharmacology

Immune Checkpoint Inhibitors - therapeutic use

Mesenchymal Stem Cells

Neoplasms - therapy

Title: Immune Checkpoint Inhibitors and Mesenchymal Stem/Stromal Cells Combination Therapy Might Offer a Promising Treatment Option for Cancer
Publication Details: Stem cell reviews and reports, Vol.19(3), pp.823-824
Resource Type: Journal article
Publisher: Springer
Grant note: R01 DK105183 / NIDDK NIH HHS R01 DK120394 / NIDDK NIH HHS R01 DK126454 / NIDDK NIH HHS R01 DK125464 / NIDDK NIH HHS R01 DK118529 / NIDDK NIH HHS I01 BX004536 / BLRD VA
Identifiers: WOS:000912614100001; 99381814267006600
Academic Unit: Biology; Hal Marcus College of Science and Engineering
Language: English